Keunwha Pharm faces government review for merger conditions

Published: 2002-09-11 06:57:00
Updated: 2002-09-11 06:57:00
The M&A agreement executed between Sanofi-Synthelabo and Keunwha Pharm on July 29 this year may be nullified due to the transaction method.

In its reply to a question raised by Keunwha Pharm, the National Tax Service (NTS) said on September 6 that the pharmaceutical business transfer agreemen...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.